BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12163454)

  • 1. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
    Rao DS; Hyun TS; Kumar PD; Mizukami IF; Rubin MA; Lucas PC; Sanda MG; Ross TS
    J Clin Invest; 2002 Aug; 110(3):351-60. PubMed ID: 12163454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.
    Bradley SV; Oravecz-Wilson KI; Bougeard G; Mizukami I; Li L; Munaco AJ; Sreekumar A; Corradetti MN; Chinnaiyan AM; Sanda MG; Ross TS
    Cancer Res; 2005 May; 65(10):4126-33. PubMed ID: 15899803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
    Bradley SV; Holland EC; Liu GY; Thomas D; Hyun TS; Ross TS
    Cancer Res; 2007 Apr; 67(8):3609-15. PubMed ID: 17440072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIP1: trafficking roles and regulation of tumorigenesis.
    Hyun TS; Ross TS
    Trends Mol Med; 2004 Apr; 10(4):194-9. PubMed ID: 15059611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
    Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
    Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts.
    Oravecz-Wilson KI; Kiel MJ; Li L; Rao DS; Saint-Dic D; Kumar PD; Provot MM; Hankenson KD; Reddy VN; Lieberman AP; Morrison SJ; Ross TS
    Hum Mol Genet; 2004 Apr; 13(8):851-67. PubMed ID: 14998932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
    Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntingtin-interacting protein 1-mediated neuronal cell death occurs through intrinsic apoptotic pathways and mitochondrial alterations.
    Choi SA; Kim SJ; Chung KC
    FEBS Lett; 2006 Oct; 580(22):5275-82. PubMed ID: 16979168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
    Nastiuk KL; Yoo K; Lo K; Su K; Yeung P; Kutaka J; Danielpour D; Krolewski JJ
    Mol Cancer Res; 2008 Feb; 6(2):231-42. PubMed ID: 18314484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
    Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
    Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.
    Bradley SV; Smith MR; Hyun TS; Lucas PC; Li L; Antonuk D; Joshi I; Jin F; Ross TS
    Cancer Res; 2007 Sep; 67(18):8923-31. PubMed ID: 17875735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
    Bromfield GP; Meng A; Warde P; Bristow RG
    Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
    Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.